A perspective on the evidence regarding methicillin-resistant staphylococcus aureus surveillance

Journal of Patient Safety

Volumn 8, Issue 3, 2012, Pages 140-143

  Kavanagh, Kevin ^a   Abusalem, Said ^a,b   Saman, Daniel M ^a  

^a Health Watch USA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

ADI; AST; evidence based medicine; HAC; HAI; healthcare associated infections; hospital acquired conditions; hospital acquired infections; methicillin resistant Staphylococcus aureus; MRSA; research integrity; research spin; surveillance; treatment standards

Indexed keywords

ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECT; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGY; PUBLISHING; REVIEW; STANDARD; STAPHYLOCOCCUS INFECTION;

CROSS INFECTION; EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PUBLICATION BIAS; STANDARD OF CARE; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 84865763966     PISSN: 15498417     EISSN: 15498425     Source Type: Journal    
DOI: 10.1097/PTS.0b013e3182627b89     Document Type: Review

References (44)

1. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003;24:362-386.
2. Farr BM, Jarvis WR. Transmission of resistant bacteria in intensive care. N Engl J Med. 2011;365:762; author reply 764-5.
3. Siegel JD, Rhinehart E, Jackson M, et al. the Healthcare Infections Control Practice Advisory Committee. Centers for Disease Control and Prevention. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Pages 15-16, 70. Available at: http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf. Accessed July 3, 2012.
4. Neely AN, Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol. 2000;38:724-726.
5. Chang S, Sethi AK, Stiefel U, et al. Occurrence of skin and environmental contamination with methicillin-resistant Staphylococcus aureus before results of polymerase chain reaction at hospital admission become available. Infect Control Hosp Epidemiol. 2010;31:607-612.
6. Shitrit P, Gottesman BS, Katzir M, et al. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol. 2006;27:1004-1008.
7. Rodríguez-Baño J, García L, Ramírez E, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol. 2010;31:786-795.
8. Clancy M, Graepler A, Wilson M, et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol. 2006;27:1009-1017.
9. Muder RR, Cunningham C, McCray E, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2008;29:702-708, 7 p following 708.
10. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43:971-978.
11. Simmons S. Effects of selective patient screening for MRSA on overall MRSA hospital-acquired infection rates. Crit Care Nurs Q. 2011;34:18-24.
12. Huang YC, Lien RI, Su LH, et al. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care unitsVa 7-year campaign. PLoS One. 2011;6:e23001.
13. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010;92:1820-1826.
14. Rao N, Cannella B, Crossett LS, et al. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res. 2008;466:1343-1348.
15. Pofahl WE, Goettler CE, Ramsey KM, et al. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg. 2009;208:981-986; discussion 986-8.
16. Nixon M, Jackson B, Varghese P, et al. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br. 2006;88:812-817.
17. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011;171:68-73.
18. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148:409-418.
19. Jain R, Kralovic SM, Evans NE, et al. Veterans Affairs Initiative to Prevent Methicillin-resistant Staphyloccus aureus Infections. N Engl J Med. 2011;364:1419-1430.
20. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to Reduce Transmission of Resistant Bacteria in Intensive Care. N Engl J Med. Page 1411. 2011;364:1407-1428.
21. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. Page 1153. JAMA. 2008;299:1149-1157.
22. Peterson LR, Diekema DJ. To Screen or Not To Screen for Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol. 2010;48:683-689.
23. O'Reilly KB. Doubt cast on effectiveness of universal MRSA screening. AMA News April 26, 2011.http://www.ama-assn.org/amednews/2011/04/25/prsb0426.htm. Accessed July 2012.
24. Morris A. Comment on Active surveillance and use of barrier precautions did not reduce colonization and infection with MRSA and VRE in adult ICUs. Ann Intern Med. 2011;155:JC2-JC13.
25. Austin J. Testimony of the Maine Hospital Association. In Opposition to LD 267VAn Act to Strengthen the Laws on Methicillin-resistant Staphylococcus aureus and to Improve Health Care. In Support Of LD 1212VAn Act to Improve Hospital Reporting of MRSA Data. April 27, 2011.
26. Jernigan JA. Prevention MRSA in healthcareVIs there a silver bullet? (Part 1 of 3)Centers for Diseases Control and Prevention. April 13, 2011. Available at: http://blogs.cdc.gov/safehealthcare/?p=1542. Accessed July 3, 2012.
27. Government Accountability Office. Health-Care Associated Infections In Hospitals. Leadership Needed from HHS to Prioritize Prevention Practices and Improve Data on These Infections. GAO-08-283 Washington, DC; 2008, pages 39-40. Available at: http://www.gao.gov/cgi-bin/getrpt?GAO-08-283 or http://www.gao.gov/new.items/d08283.pdf. Accessed July 3, 2012.
28. Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care. 2006;10:R25.
29. Kavanagh K, Abusalem S. Mounting evidence supports universal surveillance for MRSA in preoperative patients. J Am Coll Surg. 2011;213:335-336.
30. House of Representatives. Healthcare-Associated Infections: A Preventable Epidemic. Hearing before the Committee on Oversight and Government Reform House of Representatives. April 16, 2008. Available at: http://oversight-archive. waxman.house.gov/documents/20080416111629.pdf. Accessed July 3, 2012.
31. Diekema DJ, Climo M. Preventing MRSA infections. Finding it is not enough. JAMA. 2008;299:1190-1191.
32. Letter, L Response to enquiry by Congressman Waxman's health policy staff. E-Mail Oct 2, 2012. Available at: http://www.healthwatchusa.org/ publications/2012-Documents/20120202-Waxman-HAI-Hearing.pdf. Accessed July 3, 2012.
33. Cohen AL, Calfee D, Fridkin SK, et al. Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol. 2008;29:901-913.
34. Medscape General Surgery News. Section 4, July 21, 2010. Available at: http://www.medscape.com/viewarticle/723601. Accessed July 3, 2012.
35. Uçkay I, Harbarth S, Peter R, et al. Preventing surgical site infections. Expert Rev Anti Infect Ther. 2010;8:657-670.
36. Henteleff HJ, Barie PS, Hamilton SM. Members of the Evidence-Based Reviews in Surgery Group. Universal screening for methicillin-resistant Staphylococcus aureus in surgical patients. J Am Coll Surg. 2011;213:335-336.
37. Olchanski N, Mathews C, Fusfeld L, Jarvis W. Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin- resistant Staphylococcus aureus screening programs in US hospitals. Infect Control Hosp Epidemiol. 2011;32:250-257.
38. Hardy K, Price C, Szczepura A, et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect. 2010;16:333-339.
39. Cunningham R, Jenks P, Northwood J, et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect. 2007;65:24-28.
40. Jeyaratnam D, Whitty CJ, Phillips K, et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomized crossover trial. BMJ. 2008;336:927-930.
41. Boutron I, Dutton S, Ravaud P, et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:2058-2064.
42. Struelens MJ, Monnet DL. Prevention of methicillin-resistant Staphylococcus aureus infection: is Europe winning the fight? Infect Control Hosp Epidemiol. 2010;31:S42-44.
43. The Center for Disease Dynamics, Economics & Policy. (2011) Methicillin-Resistant Staphylococcus aureus. Available at: http://www.cddep.org/ ResistanceMap/bug-drug/MRSA#1. Accessed July 3, 2012.
44. Kallen AJ, Mu Y, Bulens S, et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010;304:641-648.